Former Chair of the House Budget Committee John Kasich of Ohio formally declared his candidacy for governor of Ohio June 1, 2009. His timing could not have been worse. As a Congressman, Kasich championed the North American Free Trade Agreement (NAFTA) and worldwide free trade. Now he announces for governor of Ohio, as General Motors files for bankruptcy. It will be interesting to see how Kasich, who focused recently on eliminating Ohio�s income tax, plans to explain how his free trade policies that sent tens of thousands of Ohio jobs to Mexico and China will help the state weather what looks more and more like a Depression.

With over 10% of the state�s labor force officially unemployed, Kasich will also have to explain his ties to the bankrupt and defunct investment banking firm Lehman Brothers. After leaving Congress in 2000, Kasich took a job as managing director of the Columbus, Ohio investment banking division of the company. Kasich, like the assets of Lehman Brothers, ended up with the British banking firm Barclays.

In a devastating pair of financial reports that might be called "The Emperor Has No Pressure Vessel," the New York Times has blazed new light on the catastrophic economics of atomic power.

The two Business Section specials cover the fiasco of new French construction at Okiluoto, Finland, and the virtual collapse of Atomic Energy of Canada. In a sane world they could comprise an epitaph for the "Peaceful Atom". But they come simultaneous with Republican demands for up to $700 billion or more in new reactor construction.

The Times's "In Finland, Nuclear Renaissance Runs Into Trouble" by James Kanter is a "cautionary tale" about the "most powerful reactor ever built" whose modular design "was supposed to make it faster and cheaper to build" as well as safer to operate.

But four years into a construction process that was scheduled to end about now, the plant's $4.2 billion price tag has soared by 50% or more. Areva, the French government's front group, won't predict when the reactor will open. Finnish utilities have stopped trying to guess.

At a critical moment for health care reform in the United States, The National Economic & Social Rights Initiative has published an in-depth assessment of single payer proposals, finding that a single payer system goes further towards meeting key human rights principles than market-based plans.

The question of whether national leaders will consider a single payer system as an option for health care reform has become a question of basic democracy. Despite most Americans supporting a single payer solution, the Obama Administration and congressional leaders have denied it consideration. Key stakeholders such as health care professionals, patients and single payer advocates have been excluded from hearings regarding health reform, prompting courageous civil disobedience actions by health care advocates. One of the protesters at the recent Senate Finance Hearings, Dr Margaret Flowers of PNHP Maryland, said: “We have entered a new phase in the movement for health care as a human right: acts of civil disobedience. It is time to directly challenge corporate interests. History has shown that in order to gain human rights, we must be willing to speak out and risk arrest”.

On May 19th, the American Academy of Environmental Medicine (AAEM) called on "Physicians to educate their patients, the medical community, and the public to avoid GM (genetically modified) foods when possible and provide educational materials concerning GM foods and health risks."[1] They called for a moratorium on GM foods, long-term independent studies, and labeling. AAEM's position paper stated, "Several animal studies indicate serious health risks associated with GM food," including infertility, immune problems, accelerated aging, insulin regulation, and changes in major organs and the gastrointestinal system. They conclude, "There is more than a casual association between GM foods and adverse health effects. There is causation," as defined by recognized scientific criteria. "The strength of association and consistency between GM foods and disease is confirmed in several animal studies."